NCT01493076

Brief Summary

Precut-sphincterotomy is a well established alternative after repeated futile attempts for common bile duct (CBD) cannulation with standard catheters and/or guide-wires fail. Commonly used devices instruments for pre-cutting are the needle-knife and the Erlangen-type precut-sphincterotome. In 1996 a so called "baby-sphincterotome" (Easy-Cut®, MTW, Wesel, Germany) with a pre-shaped-bended (to facilitate biliary access) small-calibre 3-French tip was developed, which enables cannulation and pre-cutting in one step. Here the investigators report on the clinical evaluation of this device.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,886

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2000

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2000

Completed
11.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2011

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

November 20, 2011

Completed
25 days until next milestone

First Posted

Study publicly available on registry

December 15, 2011

Completed
Last Updated

December 15, 2011

Status Verified

December 1, 2011

Enrollment Period

11.4 years

First QC Date

November 20, 2011

Last Update Submit

December 14, 2011

Conditions

Keywords

ERCPCannulationPrecutMini-spincterotome

Outcome Measures

Primary Outcomes (1)

  • Number of Participants with successfull bile duct cannulation

    The baby-sphincterotome was used in patients in whom biliary sphincterotomy was clinically indicated but in whomafter standard techniques to gain biliary access had failed (study population).

    Time-to-Event Outcome Measures from the beginning of the intervention until the end of the endoscopic procedure, participants will be followed for the duration of hospital stay, an expected average of 3-5 days

Secondary Outcomes (1)

  • Postinterventional compilation rate (bleeding, pancreatitis)

    Immediate or delayed complications. Time-to-Event Outcome Measures: from the beginning of the intervention till signs bleeding or panceatitis will occur. Participants will be followed for the duration of hospital stay, an expected average of 3-5 days

Study Arms (1)

Baby-S group

The baby-sphincterotome was in patients in whom biliary sphincterotomy was clinically indicated but in whom after standard techniques to gain biliary access had failed (study population).

Device: Primary cannulation/precut sphincterotomie with the Baby-S

Interventions

At the papilla the ankle for cannulation was optimized due to changes of the position of the sphincterotome, its lay in the working channel and the tension of the "Albaran"-lever and the cutting wire. After successful cannulation, the catheter with the sphincterotome inside was slightly pushed into the duct. If necessary, the baby-sphincterotome was replaced with a guide wire and than conventional endoscopic sphincterotomie was completed with a standard traction-type sphincterotome.

Also known as: Easy-Cut®, MTW, Wesel, Germany
Baby-S group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Use of the baby-sphincterotome for cannulation and pre-cut in cases of failed selective wire-guided bile duct access.

You may qualify if:

  • Evidence for bile duct obstruction with a visible stone or tumor, dilated common bile duct \> 7 mm (or \> 9 mm in cholecystectomised patients) by ultrasonography and CT-scan or MRCP/EUS, an elevated serum bilirubin level \> 1.4 mg/dl, and serum alkaline phosphatase \> 200 U/l with clinical suspicion of obstruction without evidence for cholestatic liver disease.

You may not qualify if:

  • Patients with severe coagulation disorders or distorted anatomy of the major papilla (malignant infiltration of the papilla, papillary porus not identifiable, impacted stone) and patients with former gastro-duodenal resection (e.g. BII-anatomy) were excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Foutch PG. A prospective assessment of results for needle-knife papillotomy and standard endoscopic sphincterotomy. Gastrointest Endosc. 1995 Jan;41(1):25-32. doi: 10.1016/s0016-5107(95)70272-5.

    PMID: 7698621BACKGROUND
  • Seifert H, Binmoeller KF, Schmitt T, Dietrich CF, Zipf A, Caspary WF, Wehrmann T. [A new papillotome for cannulation, pre-cut or conventional papillotomy]. Z Gastroenterol. 1999 Dec;37(12):1151-5. German.

    PMID: 10666838BACKGROUND

MeSH Terms

Conditions

Bile Duct Diseases

Condition Hierarchy (Ancestors)

Biliary Tract DiseasesDigestive System Diseases

Study Officials

  • Andrea Riphaus, MD, PhD

    Ruhr University Bochum, Department of Medicine

    PRINCIPAL INVESTIGATOR
  • Riphaus Andrea, MD, PhD

    Department of Medicine, Ruhr University Bochum

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant medical director

Study Record Dates

First Submitted

November 20, 2011

First Posted

December 15, 2011

Study Start

June 1, 2000

Primary Completion

November 1, 2011

Study Completion

November 1, 2011

Last Updated

December 15, 2011

Record last verified: 2011-12